GHIT Fund Global Health Innovative Technology Fund

Featured News

July 14, 2025PRESS

Total Investment of Approx. USD 7.3 Million in Malaria and TB R&D projects wi…

July 14, 2025EVENT

GHIT Fund to Participate in TICAD 9

July 10, 2025EVENT

【Event Report】The 11th GHIT Fund Proposal Writing Seminar (Zoom Webinar) was …

July 4, 2025NEWS

[RFP] New funding opportunity for Screening Platform

June 12, 2025PUBLICATION

GHIT's 2024 Annual Report Published

Annual Report 2021

GHIT's 2021 Annual Report is now available. The report highlights GHIT and our partners' progress and updates in FY2021: invested partnerships from discovery to clinical candidates, our portfolio, strategic plan progress, other highlighted activities, and a financial summary.

Press ReleaseArchive

July 14, 2025

Total Investment of Approx. USD 7.3 Million in Malaria and TB R&D projects wi…
April 21, 2025

Investment of Approx. USD 4.5 Million in Development of Diagnostics for Tuber…
March 17, 2025

Total Investment of Approx. USD 11.4 Million in Schistosomiasis Diagnostics a…

NewsArchive

July 4, 2025

[RFP] New funding opportunity for Screening Platform
June 10, 2025

[RFP] New funding opportunities for PD, HTLP and TRP 2025-002
June 6, 2025

Partner’s Interview: Ms. Mariko Kitahama, NEC

EventsArchive

July 14, 2025 Upcoming

GHIT Fund to Participate in TICAD 9
July 10, 2025 Past Event

【Event Report】The 11th GHIT Fund Proposal Writing Seminar (Zoom Webinar) was …
May 23, 2025 Past Event

Register Now! The 11th GHIT Fund Proposal Writing Seminar (Zoom Webinar)

PublicationsArchive

June 12, 2025 GHIT Report

GHIT's 2024 Annual Report Published
June 14, 2024 GHIT Report

GHIT’s 2023 Annual Report Published
June 25, 2023 GHIT Report

GHIT’s 2022 Annual Report Published

FilmsArchive

The 11th Proposal Writing Seminar

Transforming Global Health Through Technology: NEC’s Vision and Initiat…

Schistosomiasis: The Power of Partnership

ToolsArchive

Supported by PR TIMES: Non-profit organization project (in Japanese only)

GHIT 3.0 Strategic Plan
FY2023-FY2027

5th Anniversary Stakeholder Interviews